Yong Ho Heo

This inventor holds 4 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Ho Heo. Retrieved from https://idiyas.com/inventor/yong-ho-heo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 10)

% Patents Active = 75.0

CIPO Patents = 3 (Patent Applications = 10)

EPO Patents = 1 (Patent Applications = 18)

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 21(Granted Patents)

Location History:

Seongnam-si, KR (2018)
Hwaseong-si, KR (2021 - 2023)

Company Filing History:

4 out of 148

Hanmi Pharm. Co., Ltd.

patents

Years Active: 2018-2025

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12415842 - Immunostimulating IL-2 analogs (2025-09-16),

2. 11746137 - Immunostimulating IL-2 analogs (2023-09-05),

3. 10894089 - Long-acting insulin or insulin analogue conjugate (2021-01-19),

4. 10159715 - Method for treating diabetes comprising long-acting insulin analogue conjugate and long-acting insulinotropic peptide conjugate (2018-12-25),

Title: Yong Ho Heo: Innovator in Immunostimulating IL-2 Analogs

Introduction

Yong Ho Heo is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of immunology, particularly through his work on interleukin-2 (IL-2) analogs. With a total of four patents to his name, Heo's innovations are paving the way for advancements in immunotherapy.

Latest Patents

Yong Ho Heo's latest patents focus on immunostimulating IL-2 analogs. One of his notable inventions involves modifications to interleukin-2 alpha receptors, which are disclosed in his patents. Additionally, he has developed interleukin-2 analogs with increased binding affinity for interleukin-2 beta receptors. These advancements are crucial for enhancing the efficacy of immunotherapies.

Career Highlights

Heo is currently associated with Hanmi Pharm. Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has garnered attention for its potential to improve treatment options for various diseases.

Collaborations

Some of his notable coworkers include Dae Jin Kim and Sung Youb Jung. Their collaborative efforts contribute to the ongoing research and development in immunology.

Conclusion

Yong Ho Heo's contributions to the field of immunology through his patents on IL-2 analogs highlight his role as a key innovator. His work not only advances scientific understanding but also holds promise for future therapeutic applications.

Profile summary based on public USPTO records.